Zobrazeno 1 - 4 of 4 pro vyhledávání: '"Miriam de la Puente Yague"'
1
Akademický článek
Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines
Autor: Belen Crespo, Juan Carlos Illera, Gema Silvan, Paula Lopez-Plaza, María Herrera de la Muela, Miriam de la Puente Yague, Cristina Diaz del Arco, Paloma Jimena de Andrés, Maria Jose Illera, Sara Caceres
Publikováno v: International Journal of Molecular Sciences, Vol 25, Iss 14, p 7923 (2024)
Human inflammatory breast cancer (IBC) and canine inflammatory mammary cancer (IMC) are highly aggressive neoplastic diseases that share numerous characteristics. In IBC and IMC, chemotherapy produces a limited pathological response and anti-androgen
Externí odkaz: https://doaj.org/article/308b8e93f7fd49809e0143325a1f9b34
Zobrazit plný text záznamu
2
Akademický článek
Shared Decision-making in Breast Cancer Reconstructive Surgery: Experience in a Leading Hospital
Autor: María Herrera de la Muela, MD, PhD, Santiago Sanz Medrano, MD, Francisco Leyva, MD, PhD, Inmaculada Masa Jurado, MD, PhD, Ana I. Membrilla Ortiz, NP, Juana Brenes Sánchez, MD, PhD, Miriam de la Puente Yagüe, MD, PhD, Jorge Ruiz Rodríguez, MD, PhD, Javier Buendía Pérez, MD
Publikováno v: Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss 5, p e5846 (2024)
Background:. The paradigm of healthcare has evolved toward patient-centered approaches, where shared decision-making (SDM) plays a pivotal role. This study aimed to explore the implementation of SDM during breast cancer reconstruction consultations a
Externí odkaz: https://doaj.org/article/0d6f1c1aa5ba4dd2abfbd671b815c128
Zobrazit plný text záznamu
4
Akademický článek
Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines
Autor: Belen Crespo, Juan Carlos Illera, Gema Silvan, Paula Lopez-Plaza, María Herrera de la Muela, Miriam de la Puente Yagüe, Cristina Diaz del Arco, Maria Jose Illera, Sara Caceres
Publikováno v: International Journal of Molecular Sciences, Vol 25, Iss 3, p 1471 (2024)
The triple-negative breast cancer (TNBC) subtype is characterized by the lack of expression of ERα (estrogen receptor α), PR (progesterone receptor) and no overexpression of HER-2. However, TNBC can express the androgen receptor (AR) or estrogen re
Externí odkaz: https://doaj.org/article/cdbd349dcad343c287f7d7c0ec3f2f3f
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje